AstraZeneca
AZN
#47
Rank
A$418.53 B
Marketcap
A$134.99
Share price
-0.51%
Change (1 day)
31.84%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): A$4.73

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is A$4.56. In 2024 the company made an earnings per share (EPS) of A$3.41 an increase over its 2023 EPS that were of A$2.89.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$4.7338.58%
2024A$3.4118.23%
2023A$2.8981.13%
2022A$1.59631.03%
2021A$0.22-88.11%
2020A$1.83136.89%
2019A$0.77-39.41%
2018A$1.28-28.27%
2017A$1.78-14.37%
2016A$2.0824.11%
2015A$1.68127.55%
2014A$0.74-51.96%
2013A$1.53-58.95%
2012A$3.73-32.2%
2011A$5.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
A$4.46-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.58-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.41 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.40 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
A$5.57 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
A$30.83 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$15.69 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.11 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$16.51 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.06 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland